Literature DB >> 2312214

Long-term actions of d-fenfluramine in two rat models of obesity. II. Responses to stress.

J Carlton1, N E Rowland.   

Abstract

In the previous study (part I), we reported that a 28-day regimen of d-fenfluramine administered via osmotic pump sustained weight reductions in normal weight and obese rats without depleting brain 5-HT. Peripheral actions of d-fenfluramine were also examined. Here we extend those findings to night-time observations and to stressful conditions. This treatment regimen had no effects on night-time concentrations of insulin, triglycerides or corticosterone or on the stress-induced rise in triglycerides and corticosterone. The thermic response to cold was unaltered. Glucose tolerance was enhanced in lean, but not obese rats.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2312214

Source DB:  PubMed          Journal:  Int J Obes


  1 in total

1.  The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people.

Authors:  M L Drent; H J Adèr; E A van der Veen
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.